Volume 10, Number 4—April 2004
Dispatch
West Nile Virus, Guadeloupe
Table 1
West Nile virus IgGa antibody prevalence in horses in seven equine centers, Guadeloupe and Marie Galante, July 2002–January 2003
Place | No. tested July 2002 | Positive | Prevalence % | No. tested Jan 2003 | Positive | Prevalence % | Seroconversion rate % |
---|---|---|---|---|---|---|---|
A |
25 |
1 |
4.0 |
23 |
14 |
60.9 |
59.1 |
B |
51 |
2 |
3.9 |
44 |
27 |
61.4 |
59.5 |
C |
7 |
2 |
28.6 |
7 |
5 |
71.4 |
60.0 |
D |
13 |
5 |
38.5 |
12 |
7 |
58.3 |
28.5 |
E |
10b |
2 |
20.0 |
||||
F |
2b |
2 |
100.0 |
||||
G |
4 |
0 |
0.0 |
5 |
3 |
60.0 |
60.0 |
H |
7 |
0 |
0.0 |
9 |
3 |
33.3 |
33.3 |
I |
6 |
0 |
0.0 |
24 |
5 |
20.8 |
20.8 |
Total | 113 | 10 | 8.8 | 136 | 68 | 50.0 |
aIgG, immunoglobulin G.
bImported after July 2002.
Page created: February 09, 2011
Page updated: February 09, 2011
Page reviewed: February 09, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.